View Older Stories View More Recent Stories

May 15, 2026 04:20PM Form SCHEDULE 13G/A Corvus Pharmaceuticals, Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:20PM Form SCHEDULE 13G/A ANGIODYNAMICS INC Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:18PM Form SCHEDULE 13G/A Alto Neuroscience, Inc. Filed by: Point72 Asset Management, L.P.
May 12, 2026 04:11PM Form SCHEDULE 13G STAAR SURGICAL CO Filed by: Point72 Asset Management, L.P.
May 8, 2026 04:11PM Form SCHEDULE 13G Atara Biotherapeutics, Filed by: Point72 Asset Management, L.P.
May 1, 2026 04:11PM Form SCHEDULE 13G SUTRO BIOPHARMA, INC. Filed by: Point72 Asset Management, L.P.
Apr 29, 2026 05:32PM Form SCHEDULE 13G Janux Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
Apr 29, 2026 05:31PM Form SCHEDULE 13G Janux Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
Apr 23, 2026 06:55PM Form SCHEDULE 13G Surrozen, Inc./DE Filed by: Point72 Asset Management, L.P.
Apr 16, 2026 04:10PM Form SCHEDULE 13G CytomX Therapeutics, Filed by: Point72 Asset Management, L.P.
Apr 6, 2026 04:26PM Form SCHEDULE 13G HMH Holding Inc Filed by: Point72 Asset Management, L.P.
Apr 2, 2026 04:11PM Form SCHEDULE 13G Kodiak Sciences Inc. Filed by: Point72 Asset Management, L.P.
Apr 1, 2026 05:32PM Form SCHEDULE 13G Vera Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
Mar 11, 2026 05:25PM Form SCHEDULE 13G Korro Bio, Inc. Filed by: Point72 Asset Management, L.P.
Mar 10, 2026 06:42PM Form SCHEDULE 13G/A Celldex Therapeutics, Filed by: Point72 Asset Management, L.P.
Mar 3, 2026 04:29PM Form SCHEDULE 13G Edesa Biotech, Inc. Filed by: Point72 Asset Management, L.P.
Feb 27, 2026 08:30AM reAlpha Tech appoints Thomas Kutzman as chief financial officer
Feb 23, 2026 06:10PM Form SCHEDULE 13G Beta Bionics, Inc. Filed by: Point72 Asset Management, L.P.
Feb 19, 2026 04:59PM Form SCHEDULE 13G Q32 Bio Inc. Filed by: Point72 Asset Management, L.P.
Feb 18, 2026 05:42PM Form SCHEDULE 13G OKYO Pharma Ltd Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:38PM Form SCHEDULE 13G/A Century Therapeutics, Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:37PM Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:37PM Form SCHEDULE 13G/A Kodiak Sciences Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:36PM Form SCHEDULE 13G/A WOLFSPEED, INC. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:36PM Form SCHEDULE 13G/A ADC Therapeutics SA Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:35PM Form SCHEDULE 13G/A Verastem, Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:35PM Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:35PM Form SCHEDULE 13G/A Confluent, Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:34PM Form SCHEDULE 13G/A Cidara Therapeutics, Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:34PM Form SCHEDULE 13G/A FG Nexus Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:33PM Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:33PM Form SCHEDULE 13G/A PagSeguro Digital Ltd. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:31PM Form SCHEDULE 13G/A Alto Neuroscience, Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:30PM Form SCHEDULE 13G/A Korro Bio, Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:29PM Form SCHEDULE 13G/A PLIANT THERAPEUTICS, Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:29PM Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:29PM Form SCHEDULE 13G/A Design Therapeutics, Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:29PM Form SCHEDULE 13G/A IDEAYA Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:28PM Form SCHEDULE 13G/A WOLVERINE WORLD WIDE Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:28PM Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:27PM Form SCHEDULE 13G/A Invivyd, Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:26PM Form SCHEDULE 13G/A Aptevo Therapeutics Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:17PM Form 13F-HR Point72 Asset Management For: Dec 31
Feb 6, 2026 04:10PM Form SCHEDULE 13G IO Biotech, Inc. Filed by: Point72 Asset Management, L.P.
Jan 30, 2026 09:01AM NeOnc Technologies secures $16 million PIPE investment led by Cinctive
Jan 23, 2026 04:06PM Form SCHEDULE 13G PRECIGEN, INC. Filed by: Point72 Asset Management, L.P.
Jan 21, 2026 04:11PM Form SCHEDULE 13G Infinite Eagle Acquisiti Filed by: Point72 Asset Management, L.P.
Jan 20, 2026 04:52PM Form SCHEDULE 13G Forte Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
Jan 13, 2026 06:04PM Form SCHEDULE 13G/A KalVista Pharmaceuticals Filed by: Point72 Asset Management, L.P.
Jan 12, 2026 06:34PM Form SCHEDULE 13G KalVista Pharmaceuticals Filed by: Point72 Asset Management, L.P.
View More Recent Stories View Older Stories